DEPRECATED
This site is no longer maintained as of January 16th, 2013. Due to the increased security risks of this out-dated application , it will be decommissioned July 1st 2013. Please migrate use over to its replacement http://bioconnect.bio5.org. Direct questions and concerns to bio5admin@bio5.org. Thank you.
Linda Garland
associate professor, clinical medicine
Selected Publications
Garland L, Rankin C, Gandara D, Rivkin S, Scott K, Nagle R, Altomare D, Klein-Szanto A, Testa R, Borden E.. A phase II study of oral EGFR tyrosine kinase inhibitor erlotinib in patients with malignant pleural mesothelioma: a southwest oncology study. J Clin Oncol,, in press.
Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE. Oct 2007. Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer. Clin Cancer Res, 13:6175-81
Garland LL, Rankin C, Gandara DR, Rivkin SE, Scott KM, Nagle RB, Klein-Szanto AJ, Testa JR, Altomare DA, Borden EC. Jun 2007. Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol, 25:2406-13
Garland LL, Taylor C, Pilkington DL, Cohen JL, Von Hoff DD. Sep 2006. A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors. Clin Cancer Res, 12:5182-9
Garland LL, Hidalgo M, Mendelson DS, Ryan DP, Arun BK, Lovalvo JL, Eiseman IA, Olson SC, Lenehan PF, Eder JP. Jul 2006. A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors. Clin Cancer Res, 12:4274-82
Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, Grendys E. Jul 2004. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage, 28:7-18
Rabkin CS, Silverman S, Tricot G, Garland LL, Ballester O, Potter M. Dec 1995. The National Cancer Institute Silicone Implant/Multiple Myeloma Registry. Curr Top Microbiol Immunol, 210:385-7
Garland LL, Ballester OF, Vasey FB, Benson K, Moscinski LC, Farmelo MJ, Rodriguez MJ, Rapaport DP. Dec 1995. Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk. Curr Top Microbiol Immunol, 210:361-6